These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29866361)

  • 1. Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.
    Urban S; Bertoletti A
    Curr Opin Virol; 2018 Jun; 30():iv-vi. PubMed ID: 29866361
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus therapy: What's the future holding for us?
    Manzoor S; Saalim M; Imran M; Resham S; Ashraf J
    World J Gastroenterol; 2015 Nov; 21(44):12558-75. PubMed ID: 26640332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targets in hepatitis B virus infection.
    Stein LL; Loomba R
    Infect Disord Drug Targets; 2009 Apr; 9(2):105-16. PubMed ID: 19275699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of hepatitis B virus infection.
    Ribeiro RM; Lo A; Perelson AS
    Microbes Infect; 2002 Jul; 4(8):829-35. PubMed ID: 12270730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future therapy for hepatitis B virus infection.
    Minami M
    Clin J Gastroenterol; 2015 Aug; 8(4):167-71. PubMed ID: 26265385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic hepatitis B in pregnancy.
    Buchanan C; Tran TT
    Clin Liver Dis; 2010 Aug; 14(3):495-504. PubMed ID: 20638027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing the challenges of hepatitis B management in a developing country.
    Oluyemi A; Odeghe E
    J Infect Dev Ctries; 2012 Mar; 6(3):299-300. PubMed ID: 22421615
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus: is a cure possible?
    Zeisel MB; Baumert TF
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1129-30. PubMed ID: 27347775
    [No Abstract]   [Full Text] [Related]  

  • 11. HBV treatment: the hazy endpoint.
    Acharya SK
    Trop Gastroenterol; 2006; 27(3):103-4. PubMed ID: 17310551
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic hepatitis B: past, present, and future.
    Lai M; Liaw YF
    Clin Liver Dis; 2010 Aug; 14(3):531-46. PubMed ID: 20638030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management algorithm for interrupting mother-to-child transmission of hepatitis B].
    ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):254-256. PubMed ID: 28494542
    [No Abstract]   [Full Text] [Related]  

  • 14. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming.
    Fisicaro P; Boni C; Barili V; Laccabue D; Ferrari C
    Curr Opin Virol; 2018 Jun; 30():1-8. PubMed ID: 29414066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
    Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
    Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection.
    Lee WM
    N Engl J Med; 1997 Dec; 337(24):1733-45. PubMed ID: 9392700
    [No Abstract]   [Full Text] [Related]  

  • 18. On the way towards the eradication of chronic hepatitis B.
    Ren H
    J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of interferon-mediated antiviral immunity by hepatitis B virus: an overview of research progress.
    Guo P
    Scand J Immunol; 2013 Sep; 78(3):230-7. PubMed ID: 23790137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab.
    Buensalido JA; Chandrasekar PH
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):151-4. PubMed ID: 24341369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.